Protease-Activated Receptors 1 and 3 are Differentially Expressed on Human Monocyte Subsets and are Upregulated by Lipopolysaccharide Ex Vivo and In Vivo

Abstract Monocytes are activated in inflammatory conditions via a variety of cytokine receptors as well as in a procoagulatory setting through thrombin, acting upon protease-activated receptors (PARs). This study investigated the expression pattern of PAR1 and PAR3 on human monocyte subsets. Furthermore, a possible regulation of the expression of PAR1 and PAR3 in these cells by inflammatory activation were studied. CD16+ monocytes showed significantly higher levels of PAR1 and PAR3 as compared with CD16− monocytes. Ex vivo treatment of whole blood with lipopolysaccharide (LPS) increased PAR1 and PAR3 messenger ribonucleic acid (mRNA) in human monocytes. In addition, increase of PAR1 was seen in all three subsets upon LPS treatment, whereas PAR3 increased significantly only in CD16− monocytes and nonclassical CD16+ monocytes. Protein levels of PAR1 and PAR3 significantly increased on monocytes in vivo in human endotoxemia 1 hour after LPS infusion. PAR1 increased significantly in CD16− monocytes and nonclassical CD16+ monocytes. In this in vivo model, PAR3 was also significantly elevated in CD16− monocytes and increased slightly albeit not significantly in CD16+ monocytes. Endotoxemia increased plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF) expression in monocytes in humans. Pretreatment of healthy volunteers with the PAR1 antagonist vorapaxar blocked the increase in PAI-1 but not the increase in TF. We here provide new evidence for a critical role for monocytes as cellular mediators that contribute to the activation of coagulation in diseases characterized by an inflammatory state.

[1]  J. Wojta,et al.  Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia , 2018, Thrombosis and Haemostasis.

[2]  T. Simard,et al.  Role of plasminogen activator inhibitor-1 in coronary pathophysiology. , 2018, Thrombosis research.

[3]  B. Isermann.  Homeostatic effects of coagulation protease‐dependent signaling and protease activated receptors , 2017, Journal of thrombosis and haemostasis : JTH.

[4]  A. Siegbahn,et al.  IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets , 2017, Thrombosis and Haemostasis.

[5]  B. Jilma,et al.  Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia , 2017, European Cytokine Network.

[6]  Norbert Meyer,et al.  Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. , 2016, The Journal of allergy and clinical immunology.

[7]  H. Spronk,et al.  Coagulation and non‐coagulation effects of thrombin , 2016, Journal of thrombosis and haemostasis : JTH.

[8]  C. Weber,et al.  Role and analysis of monocyte subsets in cardiovascular disease , 2016, Thrombosis and Haemostasis.

[9]  G. Maurer,et al.  Monocyte subset distribution is associated with mortality in critically ill patients , 2016, Thrombosis and Haemostasis.

[10]  G. Maurer,et al.  Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans , 2016, Scientific Reports.

[11]  M. Nieman.  Protease-activated receptors in hemostasis. , 2016, Blood.

[12]  R. Mukherjee,et al.  Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous , 2015, Scientific Reports.

[13]  I. Moldovan,et al.  Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis , 2015, The Journal of Rheumatology.

[14]  G. Heine,et al.  Monocyte subsets in atherosclerosis , 2014, Hämostaseologie.

[15]  D. Polley,et al.  Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease , 2014, British journal of pharmacology.

[16]  M. Hollenberg,et al.  Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact , 2013, Cell Communication and Signaling.

[17]  Giuseppe Ambrosio,et al.  Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. , 2012, The New England journal of medicine.

[18]  KarineClément,et al.  CD14dimCD16+ and CD14+CD16+ Monocytes in Obesity and During Weight Loss , 2011 .

[19]  K. Clément,et al.  CD14dimCD16+ and CD14+CD16+ Monocytes in Obesity and During Weight Loss: Relationships With Fat Mass and Subclinical Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Hansen,et al.  The role of tissue factor in systemic inflammatory response syndrome , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[21]  Silvano Sozzani,et al.  Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.

[22]  H. ten Cate,et al.  Is thrombin a key player in the 'coagulation-atherogenesis' maze? , 2009, Cardiovascular research.

[23]  A. Khorana,et al.  Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer , 2008, Journal of thrombosis and haemostasis : JTH.

[24]  J. Leitner,et al.  Duffy antigen modifies the chemokine response in human endotoxemia , 2008, Critical care medicine.

[25]  A. Bredberg,et al.  Increased subpopulations of CD16+ and CD56+ blood monocytes in patients with active Crohn's disease , 2007, Inflammatory bowel diseases.

[26]  B. Jilma,et al.  Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia , 2004, Critical care medicine.

[27]  N. Mackman.  Regulation of the tissue factor gene , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Hamilton,et al.  Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes. , 1993, Blood.

[29]  J. Hamilton,et al.  Regulation of plasminogen activator inhibitor-1 levels in human monocytes. , 1993, Cellular immunology.

[30]  S. Gregory,et al.  Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin , 1989, Molecular and cellular biology.

[31]  N. Mackman,et al.  Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[32]  J. Slupsky,et al.  cells human peripheral monocytes and monocyte-derived antigen-presenting Differential expression and regulation of protease-activated receptors in , 2013 .